SMTL ID : 2pm8.1

Crystal structure of recombinant full length human butyrylcholinesterase

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

homo-octamer

Ligands

4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: P.335, G.336, S.338, N.341, N.342 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.336 NAG-NAG.19: 5 residues within 4Å: Chain C: P.335, G.336, S.338, N.341, N.342 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:G.336 NAG-NAG.37: 5 residues within 4Å: Chain E: P.335, G.336, S.338, N.341, N.342 1 PLIP interactions: 1 interactions with chain E Hydrogen bonds: E:G.336 NAG-NAG.55: 5 residues within 4Å: Chain G: P.335, G.336, S.338, N.341, N.342 1 PLIP interactions: 1 interactions with chain G Hydrogen bonds: G:G.336

20 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)

NAG.2: 3 residues within 4Å: Chain A: N.106, N.188, K.190 Ligand excluded by PLIP NAG.3: 2 residues within 4Å: Chain A: R.465, N.485 Ligand excluded by PLIP NAG.4: 3 residues within 4Å: Chain A: R.14, I.55, N.57 Ligand excluded by PLIP NAG.13: 3 residues within 4Å: Chain B: S.338, N.341, N.342 Ligand excluded by PLIP NAG.14: 4 residues within 4Å: Chain B: K.105, N.106, N.188, K.190 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain C: N.106, N.188, K.190 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain C: R.465, N.485 Ligand excluded by PLIP NAG.22: 3 residues within 4Å: Chain C: R.14, I.55, N.57 Ligand excluded by PLIP NAG.31: 3 residues within 4Å: Chain D: S.338, N.341, N.342 Ligand excluded by PLIP NAG.32: 4 residues within 4Å: Chain D: K.105, N.106, N.188, K.190 Ligand excluded by PLIP NAG.38: 3 residues within 4Å: Chain E: N.106, N.188, K.190 Ligand excluded by PLIP NAG.39: 2 residues within 4Å: Chain E: R.465, N.485 Ligand excluded by PLIP NAG.40: 3 residues within 4Å: Chain E: R.14, I.55, N.57 Ligand excluded by PLIP NAG.49: 3 residues within 4Å: Chain F: S.338, N.341, N.342 Ligand excluded by PLIP NAG.50: 4 residues within 4Å: Chain F: K.105, N.106, N.188, K.190 Ligand excluded by PLIP NAG.56: 3 residues within 4Å: Chain G: N.106, N.188, K.190 Ligand excluded by PLIP NAG.57: 2 residues within 4Å: Chain G: R.465, N.485 Ligand excluded by PLIP NAG.58: 3 residues within 4Å: Chain G: R.14, I.55, N.57 Ligand excluded by PLIP NAG.67: 3 residues within 4Å: Chain H: S.338, N.341, N.342 Ligand excluded by PLIP NAG.68: 4 residues within 4Å: Chain H: K.105, N.106, N.188, K.190 Ligand excluded by PLIP

28 x SO4: SULFATE ION(Non-functional Binders)

SO4.5: 4 residues within 4Å: Chain A: Q.316, G.413, N.414, N.415 Ligand excluded by PLIP SO4.6: 6 residues within 4Å: Chain A: H.372, Q.517, R.520, F.521, F.525 Chain F: K.528 Ligand excluded by PLIP SO4.7: 7 residues within 4Å: Chain A: S.524, F.525, K.528 Chain F: S.524, F.525, K.528 Ligands: SO4.52 Ligand excluded by PLIP SO4.8: 5 residues within 4Å: Chain A: N.228, C.400, P.401, E.404, T.523 Ligand excluded by PLIP SO4.9: 6 residues within 4Å: Chain A: Q.351, L.354, K.355, K.366, E.367, L.370 Ligand excluded by PLIP SO4.15: 4 residues within 4Å: Chain B: T.315, Q.316, N.414, N.415 Ligand excluded by PLIP SO4.16: 7 residues within 4Å: Chain B: H.372, Q.517, R.520, F.521, F.525 Chain G: K.528 Ligands: SO4.61 Ligand excluded by PLIP SO4.23: 4 residues within 4Å: Chain C: Q.316, G.413, N.414, N.415 Ligand excluded by PLIP SO4.24: 6 residues within 4Å: Chain C: H.372, Q.517, R.520, F.521, F.525 Chain H: K.528 Ligand excluded by PLIP SO4.25: 7 residues within 4Å: Chain C: S.524, F.525, K.528 Chain H: S.524, F.525, K.528 Ligands: SO4.70 Ligand excluded by PLIP SO4.26: 5 residues within 4Å: Chain C: N.228, C.400, P.401, E.404, T.523 Ligand excluded by PLIP SO4.27: 6 residues within 4Å: Chain C: Q.351, L.354, K.355, K.366, E.367, L.370 Ligand excluded by PLIP SO4.33: 4 residues within 4Å: Chain D: T.315, Q.316, N.414, N.415 Ligand excluded by PLIP SO4.34: 7 residues within 4Å: Chain D: H.372, Q.517, R.520, F.521, F.525 Chain E: K.528 Ligands: SO4.43 Ligand excluded by PLIP SO4.41: 4 residues within 4Å: Chain E: Q.316, G.413, N.414, N.415 Ligand excluded by PLIP SO4.42: 6 residues within 4Å: Chain D: K.528 Chain E: H.372, Q.517, R.520, F.521, F.525 Ligand excluded by PLIP SO4.43: 7 residues within 4Å: Chain D: S.524, F.525, K.528 Chain E: S.524, F.525, K.528 Ligands: SO4.34 Ligand excluded by PLIP SO4.44: 5 residues within 4Å: Chain E: N.228, C.400, P.401, E.404, T.523 Ligand excluded by PLIP SO4.45: 6 residues within 4Å: Chain E: Q.351, L.354, K.355, K.366, E.367, L.370 Ligand excluded by PLIP SO4.51: 4 residues within 4Å: Chain F: T.315, Q.316, N.414, N.415 Ligand excluded by PLIP SO4.52: 7 residues within 4Å: Chain A: K.528 Chain F: H.372, Q.517, R.520, F.521, F.525 Ligands: SO4.7 Ligand excluded by PLIP SO4.59: 4 residues within 4Å: Chain G: Q.316, G.413, N.414, N.415 Ligand excluded by PLIP SO4.60: 6 residues within 4Å: Chain B: K.528 Chain G: H.372, Q.517, R.520, F.521, F.525 Ligand excluded by PLIP SO4.61: 7 residues within 4Å: Chain B: S.524, F.525, K.528 Chain G: S.524, F.525, K.528 Ligands: SO4.16 Ligand excluded by PLIP SO4.62: 5 residues within 4Å: Chain G: N.228, C.400, P.401, E.404, T.523 Ligand excluded by PLIP SO4.63: 6 residues within 4Å: Chain G: Q.351, L.354, K.355, K.366, E.367, L.370 Ligand excluded by PLIP SO4.69: 4 residues within 4Å: Chain H: T.315, Q.316, N.414, N.415 Ligand excluded by PLIP SO4.70: 7 residues within 4Å: Chain C: K.528 Chain H: H.372, Q.517, R.520, F.521, F.525 Ligands: SO4.25 Ligand excluded by PLIP

20 x GOL: GLYCEROL(Non-functional Binders)

GOL.10: 5 residues within 4Å: Chain A: S.235, L.236, V.294, M.302, D.304 Ligand excluded by PLIP GOL.11: 7 residues within 4Å: Chain A: P.230, W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.12: 4 residues within 4Å: Chain A: G.75, F.76, H.77, P.429 Ligand excluded by PLIP GOL.17: 6 residues within 4Å: Chain B: W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.18: 3 residues within 4Å: Chain B: G.75, F.76, H.77 Ligand excluded by PLIP GOL.28: 5 residues within 4Å: Chain C: S.235, L.236, V.294, M.302, D.304 Ligand excluded by PLIP GOL.29: 7 residues within 4Å: Chain C: P.230, W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.30: 4 residues within 4Å: Chain C: G.75, F.76, H.77, P.429 Ligand excluded by PLIP GOL.35: 6 residues within 4Å: Chain D: W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.36: 3 residues within 4Å: Chain D: G.75, F.76, H.77 Ligand excluded by PLIP GOL.46: 5 residues within 4Å: Chain E: S.235, L.236, V.294, M.302, D.304 Ligand excluded by PLIP GOL.47: 7 residues within 4Å: Chain E: P.230, W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.48: 4 residues within 4Å: Chain E: G.75, F.76, H.77, P.429 Ligand excluded by PLIP GOL.53: 6 residues within 4Å: Chain F: W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.54: 3 residues within 4Å: Chain F: G.75, F.76, H.77 Ligand excluded by PLIP GOL.64: 5 residues within 4Å: Chain G: S.235, L.236, V.294, M.302, D.304 Ligand excluded by PLIP GOL.65: 7 residues within 4Å: Chain G: P.230, W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.66: 4 residues within 4Å: Chain G: G.75, F.76, H.77, P.429 Ligand excluded by PLIP GOL.71: 6 residues within 4Å: Chain H: W.231, V.233, T.234, E.238, R.242, V.288 Ligand excluded by PLIP GOL.72: 3 residues within 4Å: Chain H: G.75, F.76, H.77 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ngamelue, M.N. et al., Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase. Acta Crystallogr.,Sect.F (2007)

Release Date

2007-09-25

Peptides

Cholinesterase: ABCDEFGH

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

E
A

F
B

G
A

H
B

Cholinesterase